Evidence map›Paper›PMID 31659016›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.

Yan Ge, Taylor K Paisie, Sixue Chen, Patrick Concannon

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. STS2 deficiency revives CD8Journal for immunotherapy of cancer · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Functional selection in SH3-mediated activation of the PI3 kinase.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yan GeDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610; yange09@ufl.edu patcon@ufl.edu.ORCID 0000-0003-2129-9438
Taylor K PaisieDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610.ORCID 0000-0002-6024-2744
Sixue ChenGenetics Institute, University of Florida, Gainesville, FL 32610.
Patrick ConcannonDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610; yange09@ufl.edu patcon@ufl.edu.
University of Florida · US

Funding

Expression and proteomic characterization of risk loci in type 1 diabetesDP3DK085678 · NIDDK · UNIVERSITY OF VIRGINIA · PI RICH, STEPHEN S. · 2009 to 2009
$6.6M
SUSCEPTIBILITY GENES IN TYPE I DIABETESR01DK046635 · NIDDK · UNIVERSITY OF VIRGINIA · PI CONCANNON, PATRICK · 1993 to 2013
$5.4M
Novel T1D risk variants from genomic analyses in high risk familiesR01DK106718 · NIDDK · UNIVERSITY OF FLORIDA · PI CONCANNON, PATRICK · 2015 to 2018
$1.4M
NIDDK NIH HHS DP3 DK085678NIDDK NIH HHS R01 DK046635NIDDK NIH HHS R01 DK106718
6 · The paper itself

Abstract

The TCR-CD3 complex is a multicomponent membrane receptor, the expression of which is tightly regulated in thymocytes, as well as in mature T cells both at steady state and upon stimulation. In this study, we report novel roles for UBASH3A in TCR-CD3 synthesis and turnover. UBASH3A is a negative regulator of T cell function and plays a broad role in autoimmunity. We show that modulation of UBASH3A levels in unstimulated Jurkat cells leads to altered amounts of total cellular CD3 chains and of cell-surface TCR-CD3 complexes; in contrast, UBASH3A does not affect the level of cell-surface CD28, an important T cell costimulatory receptor. Upon TCR engagement, UBASH3A enhances the downmodulation of cell-surface TCR-CD3. Mass spectrometry and protein-protein interaction studies uncover novel associations between UBASH3A and components of several cellular pathways involved in the regulation of TCR-CD3 turnover and dynamics, including endoplasmic reticulum-associated protein degradation, cell motility, endocytosis, and endocytic recycling of membrane receptors. Finally, we demonstrate that the SH3 domain of UBASH3A mediates its binding to CBL-B, an E3 ubiquitin ligase that negatively regulates CD28-mediated signaling and, hence, T cell activation. In summary, this study provides new mechanistic insights into how UBASH3A regulates T cell activation and contributes to autoimmunity. The interaction between UBASH3A and CBL-B may synergistically inhibit T cell function and affect risk for type 1 diabetes, as both genes have been shown to be associated with this autoimmune disease.

Indexed as

Adaptor Proteins, Signal TransducingCD3 ComplexCells, CulturedHEK293 CellsHumansJurkat CellsReceptors, Antigen, T-CellAdaptor Proteins, Signal TransducingCD3 ComplexReceptors, Antigen, T-CellUBASH3A protein, human

Identifiers

PMID31659016
PMCPMC6938261
OpenAlexW2982615280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.